UNITED STATES PATENT AND TRADEMARK OEEICE
`
`
`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMNIISS IONER FOR PATENTS
`PO Box 1450
`Alexandria, Virginia 22313-1450
`www.uspt0 gov
`
`APPLICATION NO.
`
`14/096346
`
`ISSUE DATE
`
`09/22/2015
`
`PATENT NO.
`
`9138456
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`2832
`
`210
`
`7590
`
`09/02/2015
`
`MERCK
`P 0 BOX 2000
`RAHWAY, NJ 07065—0907
`
`The projected patent number and issue date are specified above.
`
`ISSUE NOTIFICATION
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment is 0 day(s). Any patent to issue from the above-identified application will include
`an indication of the adjustment on the front page.
`
`If a Continued Prosecution Application (CPA) was filed in the above-identified application, the filing date that
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information
`Retrieval (PAIR) WEB site (http://pair.uspto. gov).
`
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the
`Office of Patent Legal Administration at (571)-272-7702. Questions relating to issue and publication fee
`payments should be directed to the Application Assistance Unit (AAU) of the Office of Data Management
`(ODM) at (571)-272-4200.
`
`APPLICANT(S) (Please see PAIR WEB site http://pairllspto gov for additional applicants):
`
`Cubist Pharmaceuticals, lnc., Lexington, MA;
`S andra O'Connor, Hudson. NH;
`Sophie Sun, Lexington, MA;
`Gaauri Naik, Cambiidge, MA;
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location
`for business investment, innovation, and commercialization of new technologies. The USA offers tremendous
`resources and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation
`works to encourage and facilitate business investment. To learn more about why the USA is the best country in
`the world to develop technology, manufacture products, and grow your business, visit SelectUSAgov.
`
`IR103 (Rev. 10/09)
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`
`
`:har'gc(5) EPPIICC]
`O ‘Jocum‘m "24
`M-CIi/
`Z
`ZOI 5
`
`20120270772
`
`2012—10—25
`
`20090197799
`
`2009—08—01
`
`20020111311
`
`2002—08-01
`
`200701 16729
`
`25
`
`26
`
`27
`
`03Connor et aI.
`CUB'ST PHARMA
`'
`
`'
`
`Keith et al.
`
`Govardhan et al.
`
`
`
`2007—05—01
`
`
`
`
`
`
`
`Receipt date: 01/06/2014
`
`INFORMATION DISCLOSURE
`
`STATEMENT BY APPLICANT
`
`(Not for submission under 37 CFR 1.99)
`
`
`
`
`Application Number
`14096346
`14096346 ~ GAL]: 1676
`
`Filing Date
`2013-12-04
`
`First Named Inventor
`Sandra O'Connor
`
`
`Art Unit
`| 4954:
`1 6 7 6
`Examiner Name
`Li Komatsu
`
`Attorney Docket Number
`
`I 552815 (CPT—O11USDV)
`
`23
`
`20110207658
`
`2011-08-25
`
`Kelleher, Thomas J.
`
`
`
`
`
`
`
`If you wish to add additional U.S. Published Application citation information please click the Add button. Add
`
`.
`.
`.
`Examiner Cite Foreign Document
`Initia|"
`No
`Number3
`
`1
`
`2
`
`3
`
`4
`
`W02001l044274 A1
`
`W020011053330 A2
`
`WOZOOZ/055537 A1
`
`WOZOOZIUSBBZQ A2
`
`FOREIGN PATENT DOCUMENTS
`
`REMOVE
`
`.
`.
`Publication
`Date
`
`Name of Patentee or
`A Iicant of cited
`pp
`Document
`
`Pages,Cqumns,Lines
`where Relevant
`Passages or Relevant
`Figures Appear
`
`2001-06-21
`
`CUBIST
`PHARMACEUTICALS,
`INC
`
`2001-07-26
`
`CUBIST
`PHARMACEUTICALS,
`INC
`
`2002—07—18
`
`INTRABIOTICS
`PHARMACEUTICALS,
`INC.
`
`2002—07-25
`
`CUBIST
`PHARMACEUTICALS,
`INC
`
`EFSWeb2.1.17
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/L.K./
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`
`
`Receipt date: 01/00/2014
`
`INFORMATION DISCLOSURE
`
`STATEMENT BY APPLICANT
`
`(Not for submission under 37 CFR 1.99)
`
`
`Application Number
`14096346
`14090346 ~ GAL]: 1070
`
`Filing Date
`2013-12-04
`
`First Named Inventor
`Sandra O'Connor
`
`An Unit
`Examiner Name
`
`| 1954s
`
`Attorney Docket Number
`I 552815 (CPT—O11USDV)
`
`1. 5 76
`Li Komateu
`
`
`
`
`12
`
`20060018934
`
`2006—01-26
`
`Vaya, Navin
`
`
`
`14
`Change (5) aPPiieci
`to I n
`n ‘ |
`
`/M-C9E-/
`
`5 29/201 5 15
`
`13
`
`16
`
`17
`
`18
`
`19
`
`20060024365
`
`20060264513
`
`20060269485
`
`20070116729
`
`20070191280
`
`20080220441
`
`20090197799
`
`2006—02—02
`
`Vaya, Navin
`
`Leonobay et ai.
`2006—11-23 WWW
`
`2006—11—30
`
`Friedman, Doron
`
`2007—05—24
`
`Palepu, Nageswara R.
`
`2007—08—16
`
`Kelleher, Thomas
`
`2008—09—11
`
`Birnbaum, Eva R.
`
`2009—08—06
`
`Keith, Dennis
`
`
`
`
`
`
`
`
`
`
`
`
`
`FaiePu et ai.
`’
`EAGLE PHA
`2011—05—26
`20110124551
`21
`
`
`20
`
`20100041589
`
`2010-02-18
`
`Keith, Dennis
`
`22
`
`20110172167
`
`2011—07—14
`
`FaicPu et ai.
`EAGLE PHARMA
`
`,
`
`EFSWeb2.1.17
`
`ALL REFERENCES CONSiDERED EXCEPT WHERE LiNED THROUGH.
`
`/L.K./
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`
`
`Receipt date: 01/06/2014
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Not for submrssmn under 37 CFR 1.99)
`
`
`Application Number
`14096346
`14096346 ~ GAL]: 1676
`
`Filing Date
`2013-12-04
`
`First Named Inventor
`Sandra O'Connor
`Art Uni,
`iW
`16 76
`.
`Examiner Name ‘ _ 3W L J. Koma ii 8 U
`
`Attorney Docket Number
`
`|552815 (CPT—O11USDV)
`
`
`
`Govardhan, et 31.
`(J angers a PHC
`2002 08 15
`20020111311
`m amumcnt’ 1
`-
`- Cubist-Film
`..
`/M.L.li./
`’
`
`5 29/2015
`
`
`
`
`
`
`
`2
`
`3
`
`4
`
`5
`
`6
`
`7
`
`8
`
`9
`
`10
`
`20020132762
`
`20030045484
`
`20030045678
`
`20040067878
`
`20040077601
`
`20040242467
`
`20050009747
`
`20050196418
`
`20060014674
`
`2002-09-19
`
`Borders, Donald B.
`
`2003-03-06
`
`Keith, Dennis
`
`2003-03-06
`
`Keith, Dennis
`
`2007-04-08
`
`Hill, Jason
`
`2004—04—22
`
`Adams, Sharlene
`
`2004—12-02
`
`Borders, Donald B.
`
`2005—01—13
`
`Kelleher, Thomas
`
`2005—09-08
`
`Yu, Ruey J.
`
`2006—01—19
`
`Keith, Dennis
`
`
`
`
`
`
`
`
`
`11
`
`20060018933
`
`2006—01-26
`
`Vaya, NaVin
`
`EFSWeb2.1.17
`
`ALL REFERENCES CONSlDERED EXCEPT WHERE LtNED THROUGH.
`
`/L.K./
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`14096346 ~ Gamma
`8ssdet£atei 01/06/2014
`Approved for use through 0713119012. OMB 0651-0031
`1
`.
`.
`_
`.
`.
`us. Patent and Trademark Office; us. DEPARTMENT OF COMMERCE
`Doc description. Information Disclosure Statement (IDS) Filed
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`
`
`
`
`
`
`
`Application Number
`14096346
`
`Filing Date
`2013—12—04
`First Named Inventor
`Sandra O'Connor
`
`A11 Unit
`I
`as
`1676
`
`Examiner Name
`‘
`Li Biometsu
`Attorney Docket Number
`|552815 (CPT—O11USDV)
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Not for submisswn under 37 CFR 1.99)
`
`
`
`
`U.S.PATENTS
`Remove
`
`Name of Patentee or Applicant Pages,Columns,Lines where
`Kind
`Examiner Cite
`.
`Relevant Passages or Relevant
`.
`.
`,,
`Initial
`No
`Code1
`of Cited Document
`.
`Figures Appear
`
`
`Patent Number
`
`Issue Date
`
`1
`
`6696412
`
`2004—02—24
`
`Thomas J. Kelleher
`
`
`
`C ange<sj aPPficd
`
`to document,
`
`6716962
`
`2004-04-06 W
`
`borders,
`
`6’: al.
`
`7138487
`
`2006-11-21 “MW
`
`borders: ct al.
`
`7279597
`
`61: al,
`Leone~bag,
`2007-10-09 W
`
`/IVICI:~/
`
`5/19/1015
`
`3
`
`4
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`8058238
`
`61: al.
`Kelleher,
`2011-11-15 WW
`
`8003673
`
`2011-08-23
`
`Alder et al.
`
`5
`
`6
`
`
`
`
`If you wish to add additional US. Patent citation information please click the Add button.
`Add
`
`U.S.PATENT APPLICATION PUBLICATIONS
`Remove
`
`
`
`Examiner
`.
`.
`*
`Initial
`
`
`
`.
`Cite No
`
`Publication
`Number
`
`Publication
`Kind
`Code1 Date
`
`
`
`Name of Patentee or Applicant Pages,Columns,Lines where
`.
`Relevant Passages or Relevant
`of Cited Document
`.
`Figures Appear
`
`
`
`EFSWeb2.1.17
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/L.K./
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`
`
`Receipt date: 01/06/2014
`
`INFORMATION DISCLOSURE
`
`1 4096346 14096346 ~ GAU: 1676
`
`Application Number
`2013-12-04
`Filing Date
`Sandra O'CONNOR
`First Named Inventor
`
`
`
`STATEMENT BY APPLICANT
`_
`_
`(Not for submissmn under 37 CFR 1.99)
`
`Ait Unit
`
`1.6 7g;
`
`Examiner Name
`Attorney Docket Number
`
`L1, Kematsu
`|552815 (CPT—O11USDV)
`
`Examiner
`.
`.
`,,
`Initial
`
`.
`Cite No
`
`Publication
`Number
`
`U.S.PATENT APPLICATION PUBLICATIONS
`
`Remove
`
`
`Publication
`Name of Patentee or Applicant Pages,Columns,Lines where
`Kind
`
`.
`Relevant Passages or Relevant
`of Cited Document
`Code1 Date
`.
`
`Figures Appear
`
`1
`
`2
`
`3
`
`20120149062
`
`2012-02-16
`
`Kelleher et al.
`
`20100041589
`
`2010-02-18
`
`Keith et al.
`
`20120270772
`
`2012-07-10
`
`
`
`
`
`4
`
`5
`
`20050027113
`
`2005-02-03
`
`Vivian Pak Woon Miao et al.
`
`20070128694
`
`2007—06-07
`
`Baltz et al.
`
`Kelleher ct al.
`
`c" 3 when‘
`+12.
`C lo I
`all
`clocumcnt
`t
`
`/l\/l~C-l:~/
`5 29/2015
`
`6
`
`20130280760
`
`A1
`
`2013-10-24
`
`'eflbisf-Pl-rurmaeeH-tieale-Ine-
`
`If you wish to add additional U.S. Published Application citation information please click the Add button. Add
`
`FOREIGN PATENT DOCUMENTS
`REMOVE
`
`
`
`
`
`
`
`Examiner Cite Foreign Document
`|nitia|*
`No
`Number3
`
`Country
`Code2 i
`
`Publication
`Kind
`Code4 Date
`
`WO 00018419
`
`2000—04—06
`
`
`
`1
`
`2
`
`
`
`
`
`Name of Patentee or
`A Iicant of cited
`pp
`Document
`
`Cubist Pharmaceuticals
`
`Pages,Cqumns,Lines
`where Relevant
`Passages or Relevant
`.
`Figures Appear
`
`T5
`
`
`
`
`
`WO 99027957
`
`1999-06-10
`
`Else 'mmune ReSponse
`
`
`
`EFS Web 2.1.17
`
`ALL REFERENCES CONSiDERED EXCEPT WHERE LiNED THROUGH.
`
`/L.K./
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`
`
`Receipt date: 01/06/2014
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Not for submission under 37 CFR 1.99)
`
`
`Application Number
`14096346
`14096346 ~ GAL]: 1676
`
`Filing Date
`2013-12-04
`
`First Named Inventor
`Sandra O'CONNOR
`
`
`A” Unit 16 76 l
`Examiner Name
` Li Komatsu
`Attorney Docket Number
`I 552815 (CPT—O11USDV)
`
`
`
`
`9
`
`4482487
`
`1984-11-13
`
`Abbott et al,
`
`
`
`
`
`10
`
`1 1
`
`12
`
`13
`
`14
`
`15
`
`
`
`4331594
`
`1982-05-25
`
`Hamill et al.
`
`4439425
`
`1984-03-27
`
`Ta rcsay et al.
`
`5336756
`
`1994-08-09
`
`Schwartz et al.
`
`8431539
`
`2013-04-30
`
`Palepu et al.
`
`6696412
`
`8309061
`
`2004—02—24
`
`Kelleher et al.
`
`to cloc iment7
`
` Chang {5) applied
`
`2012-11-13
`
`
`
`
`
`
`
`
`
`If you wish to add additional US. Patent citation information please click the Add button.
`U.S.PATENT APPLICATION PUBLICATIONS
`
`.
`Examiner
`,,
`.
`.
`Initial
`
`.
`Cite No
`
`.
`.
`Publication
`Number
`
`.
`.
`.
`Publication
`Kind
`Code1 Date
`
`.
`Name of Patentee or Applicant
`.
`of Cited Document
`
`Add
`Remove
`
`Pages,Cqumns,Lines where
`Relevant Passages or Relevant
`Figures Appear
`
`
`If you wish to add additional U.S. Published Application citation information please click the Add button. Add
`
`FOREIGN PATENT DOCUMENTS
`
`Remove
`
`EFSWeb2.1.17
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/L.K./
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`14096346 ~ 51519191015215
`8512519111336: 01/06/2014
`Approved for use through 0713119012. OMB 0651-0031
`1
`.
`.
`_
`.
`.
`us. Patent and Trademark Office; us. DEPARTMENT OF COMMERCE
`Doc description. Information Disclosure Statement (IDS) Filed
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`
`
`
`
`
`
`
`Application Number
`14096346
`
`Filing Date
`2013—12—04
`First Named Inventor
`Sandra O'CONNOR
`
`An Unit
`l
`as
`1676
`Examiner Name
`Li Koma: Su
`Attorney Docket Number
`|552815 (CPT—O11USDV)
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`(Not for submisswn under 37 CFR 1.99)
`
`
`
`
`
`
`
`
`Name of Patentee or Applicant Pages,Columns,Lines where
`Kind
`Examiner Cite
`.
`Relevant Passages or Relevant
`.
`.
`,,
`Initial
`No
`Code1
`of Cited Document
`.
`Figures Appear
`
`
`Patent Number
`
`Issue Date
`
`
`
`
`U.S.PATENTS
`Remove
`
`1
`
`6194383
`
`2001—02—27
`
`Hammann et al.
`
`
`
`2
`
`5955509
`
`1999-09-21
`
`Webber et al.
`
`
`
`3
`
`5629288
`
`1997-05-13
`
`Lattrell et al.
`
`
`
`4
`
`5387670
`
`1995-02-07
`
`Roy et al.
`
`
`
`5
`5271935
`1993-12-21
`Franco et al.
`kangeCS) applied
`
`’5 document,
`
`6
`
`4882164
`
`1989-11-21
`
`Ferro
`
`/ .KC/
`
`6 10/2015
`
`
`
`7
`
`8
`
`4331594
`
`Hamill et al.
`1982-05-25 W
`
`8604164
`
`2013—12—10
`
`Kelleher et al.
`
`
`
`If you wish to add additional US. Patent citation information please click the Add button. Add
`
`EFSWeb2.1.17
`
`ALL REFERENCES CONSlDERED EXCEPT WHERE LlNED THROUGH.
`
`/L.K./
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`APPLICATION NUMBER
`
`FILING OR 371(C) DATE
`
`14/096,346
`
`12/04/2013
`
`113613
`
`Lathrop & Gage
`28 State Street
`Boston, MA 02109-1775
`
`UVITET‘I STATES DEPAR'IWIFN'I‘ 0F COM—MERGE
`United States Patent and Trademark Office
`Addless. COMMISSTOVFR FOR PATENTS
`PO Box 1450
`Alexandriay‘hjgnia 22313-1450
`wvmmsptogov
`
`FIRST NAB/[ED APPLICANT
`
`ATTY. DOCKET NOJTITLE
`
`Sandra O'Connor
`
`23961-US-DIV
`CONFIRMATION NO. 2832
`POWER OF ATTORNEY NOTICE
`
`l|||l|||||||||||||||||Illllllllllllllllllll||l|||||||l|||||||ll||l||||ll|l|ll|l||l||||llll
`000000076859236
`Date Mailed: 08/14/2015
`
`NOTICE REGARDING CHANGE OF POWER OF ATTORNEY
`
`This is in response to the Power of Attorney filed 08/10/2015.
`
`- The Power of Attorney to you in this application has been revoked by the assignee who has intervened as
`provided by 37 CFR 3.71. Future correspondence will be mailed to the new address of record(37 CFR 1.33).
`Questions about the contents of this notice and the
`
`requirements it sets forth should be directed to the Office
`of Data Management, Application Assistance Unit, at
`(571) 272-4000 or (571) 272-4200 or 1-888-786-0101.
`
`/LhiII/
`
`
`
`page 1 of 1
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`UVTTET‘I STATES DEPARTWFNT 0F COM'MERCF}
`United States Patent and Trademark Office
`Address. COMMTSSTOVFR FOR PATENTS
`PO Box 1450
`Alexandtia) Vugnia 22313-1450
`wvmmspto.gov
`
`FIRST NAMED APPLICANT
`APPLICATION NUMBER
`FILING OR 371(C) DATE
`ATTY. DOCKET No./TITLE
`
`14/096,346
`12/04/2013
`S andra O'Connor
`CON FIRMATION NO. 2832
`POA ACCEPTANCE LETTER
`
`210
`M E RCK
`P 0 BOX 2000
`RAHWAY, NJ 07065-0907
`
`l|||l|||||||||||||||||Illllllllllllllllllll|||l|||||||l||||||l|||l||||l||l||||||||||||l|||
`0000000768592 8
`Date Mailed: 08/14/2015
`
`NOTICE OF ACCEPTANCE OF POWER OF ATTORNEY
`
`This is in response to the Power of Attorney filed 08/10/2015.
`
`The Power of Attorney in this application is accepted. Correspondence in this application will be mailed to the
`above address as provided by 37 CFR 1.33.
`
`Questions about the contents of this notice and the
`
`requirements it sets forth should be directed to the Office
`of Data Management, Application Assistance Unit, at
`(571) 272-4000 or (571) 272-4200 or 1-888-786-0101.
`
`/1hill/
`
`
`
`page 1 of 1
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`PART B - FEMS) 'l‘RANSMH'TAL
`
`Complete and send this farm, lngethcr with applicable. FEMS), t0: Maj! Mail Stop ISSUE FEE
`‘
`C(Jmmissimer for Patents
`1".0 Box 1450
`Alexandria. Virginia223l3—1153
`or has 5‘2'1}-2732885
`
`
`
`
`uNthUL'I'W‘NS This Yum: :huuld be used .L‘sr transmitting the {551L H“E 21nd !‘\.11)J..TT(VION F "" {it matured). Blinks 1 through. should be. Llompimsd where
`a;grandam.All fmihcr mmsgumdznce inaludmg the. Ram“ advamzc UIdGIS and natiiicatiou ml maimtnancc Fto‘ w l be mailed to £12: mama: cmmsrnmdmce addms: m
`
`
`in» lizard UniES: corrected below ~er dircczed oxhemisL in Him}; l by (.5: spwiiying a new ummpuudmu address; andforfb} indicating a ELPZUJ‘B “1'1 1. ADDR‘L\. for
`maintenance iet‘. notifi:minus.
`
`
`(EVERENT CGR gamma ' E ADDRESS ENm'L; Um Black 1 Re: any {flange of iiddmas)
`
`-m
`
`1.1.1513
`w.
`'
`
`'
`
`‘
`
`'3
`
`"'r
`
`”’5'"
`‘_, .
`
`..
`\
`
`-
`
`..
`
`..
`
`,
`
`.
`
`_
`‘
`"5'" “am".
`Merck Sharp a Dannie chp.
`126 East‘ Lincolr: AVE .
`
`
`\i‘ic: A c-zru'fiLaic L-f mailing can out}, b. Uitd fa; domesti: smifings 0" tin
`
`Ft-L } Tmnsrsut‘iii. l'hia I:Ltillcatt: unmet be med 1'
`nnx- urhcr amtimpanying
`Fa
`i‘ach additional paper sui‘ii as an asaisuimeul u.“ furn‘al thawing. musi
`my: its mm certificate hf mailing or trim:missmn.
`Certificate of Maiiing or Transmissinn
`
`1"mere!0'} EEK v fi‘al this Feeis
`. a Liemailed with the\‘nited
`
`em‘c swimsuit
`ntfmgfixgat
`AL}: mmilinmzmlmm
`Sta:asl’ostal
`
`
`L.
`LE address zbme. or being facaimie.
`tha VI 1
`addiesgad to.
`transmitted in tin.
`
`732335 rm the dateindicated. bell-u».
`A
`
`Railway, New Jersey C‘més
`(‘ONTL‘O‘STION J.
`
`FILI‘JGDATES
`
`FmS’l‘NAMEDENVENTDR
`
`.-‘\‘]‘T-.“_3R:\“E
`
`lXHI'KZi'f‘NU
`
`Sandra O'Cunnor
`336342923
`14.15% 34(-
`TITLE OF LVVEN'I‘TOE‘Y: 1.1POEF'I‘EIVE'1DE CUP-IEE'OSI’l‘iONS AND RELA'E'EU METHODS
`
`552$15: ("FT?Oi ‘LUSDV‘
`
`" '
`
`'
`
`2833.
`
`
`
`lI APPLN. TYPE ENTZ'EY STATUS I {8583351 REE DIE FUELICATEON FEED-l2 PREV. PAJIJ I- - » 'J'D'E'AL FE“:
`nouprm‘isiomll
`' UNDISCOUN'JED
`55960
`50
`$0
`33960
`[1811312015
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`(TiASS-SL‘BCL EXAMINER ' [\RTE'UNET
`ROMAISIS. Ll :\
`157-5
`rim-[Ill ltlii-
`'2. Fm printing up the patent front page. lite:
`
`
`
`l. Changcatmuespnmleme adding up juditman (21‘Pa Address“ (3.,
`
`[711R l363)
`{I}. The uam .
`:5 {1'0 m\ I:gistere-d patent attorneys
`
`Gl‘ agents OR . [L‘mativciv
`E] than? of cot-rec. mume midi-ass {m {hangs. of (.ormsponden
`Addie4». Vin PTO:55:12:; attached
`
`(_ in: nirm‘. 0F :1 single iinn (havino 2153TUCIHIX‘K a
`9.
`
`U'‘FLeAddm'sx‘ 111211“!in (m ‘ch: Address‘ Emit:mm Laws
`mgiswr‘d attorney )1“agent) and thenames uf up L0
`
`PTOISB/d‘}: Rerou- (>2 mmom.eccnt}.1r£:mhz\i Isa-«fa Customer
`e rt.Wham“! pat.
`ya or ugz:nls ll no (Lam: i5
`
`Kim-Ii. nu warm.
`med
`\umhm‘IS itquiied.
`
`
`
`
`ill) ON THE} PATENTr‘
`3 ASSiCrVEm NAME AND RESIDENCE DATA TO BE FEM '1
`
`
` Hit or t)" pa)
`
`Pf A33 "40W“’:nlcss .‘Lu assiamu: is iiknlified balmy no as»! “-
`l‘° an :usigmu is idmiifiau below the ducumcflt ha; {761m tiled f0:
`cull-i will Appear \m the patent.
`.vmlatimi as
`1
`
`
`1 forthin 3'? KIT-TI 3.. 1.Loxiipl\‘tion oi thié-. farm IS NOT a aiihstihiii. fm‘ filing an fisignmeni.
`
`
`; ma 0:: ASSIG-NEE
`(a; R;.:SIDE:\'(ZF‘:.: {CITY and 5 mm m: cow-I'm;
`Cubist Plasma?euti. Gals L-Li‘i
`Renalworm? New Jersey
`
` m
`
`R: w‘ERIN“
`9325’23F'DUJ-1
`
`'8 .3 2'
`"
`.:. 53 9
`
`P1633:. check the appropriate 35>igm6 Lategov Ur Cattgowns {Will not be printed on. the patent): D individual 53 C‘mpciafion or new: {Mixate group 83.1le E! t'ieve’rnment
`411. The folanWing Feds), are submitted
`4b. Payment of Fan’s); (Please first mappiy any pmviousty paid hustle fet- shown ahave)
`«.3 lssuei“at!
`~J A check15 em.losvd
`in Publication Fee {No small antity‘diswm permitted)
`:1 Pancnl by credit mud. E‘nnn PTO-2038 is numbed.
`
`3 Advance. Order— 9% oic‘fipifs
`
`‘1'Elle director 25 hereby authcrized to charge the required feels). an}? d:ficicm ' or Hedi" any
`fli‘l‘PGlt‘SG an it‘\[l;1 cap} of tth h:In“;
`owmm1))an KC: Depacsit Account \umber 'l ’
`'31,)“
`
`{:3 Applicant asserting Email entity stanza. Sec“.37 CIFR 1.3
`
`fi. (Thange in Entity Shims {from Status indicated abe‘w)
`D Applicant certifying mitm cntaty status. See. 1‘37 CFR 1.29
`
`
`
`Nng g: Ahsmt a walid cmfificaiicm cf M'36:01int-iv Status (is: ' my; PTOJSBJ'JSA and 153). issue.
`tee pasinn-m in this micr0 emiw max-tut will :29: b5 stemmed m the
`k of nppliuuinn abandonment
`N61113:?!” Liteapplkmien was predousiy under micro entiw smut checking this box will be [.3an
`to EL a notification of loss umei demcnl to mica) entity slams
`e‘59, 1'1; Checking this box will be {aim to be a nutiiicatitza oi loan 91‘ But} Clement to small U: Illicit)
`iai‘ undismumfil fer slams.
`Cl {\ppbmm Changing 10 PL-
`eumv 31mm as appfscnbk
`“
`
`
`
` N01131:“ his fault musiht. si ' i'a mll 131 and l 33, Se: 3”? CIRI4 far :ivnaiurt re‘ timmeni: 9453 C?
`
`
`ificriliusis
`
`""
`"
`.
`i
`« z
`
`
`Authorited Signatum, 1V,sit-{:55 ”(jar.
`‘8
`‘3-
`”\g.‘
`{a
`anne Pacer
`
`Typed or primed name
`
`P103.»35 PM!)"' {19'139APUOVed far use. tlunugh 10:3152113.
`
`(1MB 065143033
`
`US. Patent and 'l'rademar}; Ollicc: 73.5. DEPARTMENT UP COMMERCE
`
`Page 2 of 3
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`
`
`Electronic Patent Application Fee Transmittal
`
`Filing Date:
`
`04-Dec-2013
`
`Title of Invention:
`
`LIPOPEPTIDE COMPOSITIONS AND RELATED METHODS
`
`
`
`First Named Inventor/Applicant Name: Sandra O'Connor
`
`Filer:
`
`Dianne Pecoraro/Pia Paras—Sanjurjo
`
`Attorney Docket Number:
`
`552815: CPT—OHUSDV
`
`Filed as Large Entity
`
`Filing Fees for Utility under 35 USC111(a)
`
`Sub-Total in
`Description USD($) Quantity
`
`
`
`
`
`
`
`Basic Filing:
`
`Miscellaneous-Filing:
`
`Petition:
`
`Patent-Appeals-and-lnterference:
`
`Post-AlIowance-and-Post-lssuance:
`
`
`Utility Appl Issue Fee
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`
`
`
`
`Sub-Total in
`Description USD($) Quantity
`
`Total in USD (5)
`
`Extension-of—Time:
`
`Miscellaneous:
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`Electronic Acknowledgement Receipt
`
`23188623
`
`Confirmation Number:
`
`Title of Invention:
`
`LIPOPEPTIDE COMPOSITIONS AND RELATED METHODS
`
`
`
`
`
`First Named Inventor/Applicant Name:
`
`Sandra O'Connor
`
`Customer Number:
`
`113613
`
`
`
`Filer Authorized By: Dianne Pecoraro
`
`Attorney Docket Number:
`
`552815: CPT—011USDV
`
`Filing Date:
`
`04-DEC-2013
`
`14:40:19
`Time Stamp:
`
`
`
`
`Application Type: Utility under 35 USC 111(a)
`
`Payment information:
`
`Submitted with Payment
`PaymentType Deposit Account
`
`
`
`Payment was successfully received in RAM
`
`$960
`
`Deposit Account
`
`Authorized User
`
`132755
`
`PECORARO, DIANNE
`
`The Director ofthe USPTO is hereby authorized to charge indicated fees and credit any overpayment as follows:
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`Charge any Additional Fees required under 37 CFR. Section 1.20 (Post Issuance fees)
`
`
`
`File Listing:
`
`Document
`Number
`
`Document Descri
`
`tion
`
`P
`
`FileSize(Bytes)/
`Message Digest
`416726
`
`Pages
`Multi
`Part /.zip (ifappl.)
`
`Issue Fee Payment (PTO-85B)
`
`23961-Execlfee-12Aug2015.pdf dbSabdeeblieUIbdQUQfibllb laQSQUeb/IS
`24c8bc
`
`
`
`New International Application Filed with the USPTO as a Receiving Office
`lfa new international application is being filed and the international application includes the necessary components for
`an international filing date (see PCT Article 11 and MPEP 1810), a Notification of the International Application Number
`and of the International Filing Date (Form PCT/RO/105) will be issued in due course, subject to prescriptions concerning
`national security, and the date shown on this Acknowledgement Receipt will establish the international filing date of
`the application.
`
`Information:
`
`Fee Worksheet (SBOG)
`
`fee—info.pdf
`
`infimhfifiil Pf4r=hhfi§fi7l 77087f764df8P
`SI06
`
`Information:
`Total Files Size (in bytes)l 447182
`
`
`
`This Acknowledgement Receipt evidences receipt on the noted date by the USPTO of the indicated documents,
`characterized by the applicant, and including page counts, where applicable. It serves as evidence of receipt similar to a
`Post Card, as described in MPEP 503.
`
`New Applications Under 35 U.S.C. 111
`lfa new application is being filed and the application includes the necessary components for a filing date (see 37 CFR
`1.53(b)—(d) and MPEP 506), a Filing Receipt (37 CFR 1.54) will be issued in due course and the date shown on this
`Acknowledgement Receipt will establish the filing date ofthe application.
`
`National Stage of an International Application under 35 U.S.C. 371
`Ifa timely submission to enter the national stage of an international application is compliant with the conditions of 35
`U.S.C. 371 and other applicable requirements a Form PCT/DO/EO/903 indicating acceptance of the application as a
`national stage submission under 35 U.S.C. 371 will be issued in addition to the Filing Receipt, in due course.
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`PTOI’AEA/EICI iii-742)
`Apprcved for use through 111'30/‘2014. OMB (3651x0035
`U 8. Pete.It and Trademark OttiCa; U S DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995 no persons are reuuired to Iespend to a ceiiect:on of information unless it displays a vaiid OMB cantrei IIUIII‘oeI.
`
` PG‘WER 53F ATTGRNEY T9 PRQSECQTE APPLECATEQNS BEFQRE THE {ESPTQ
`
`}
`
`i hereby {evoke all preVIous powers of attorney given In the app cation Iden tied in the atiac ed tatement
`under 3? CFR 373’s.
`
`i hereby appoint:
`
`Practitienei's aI
`
`ated with Customer Number
`
`‘
`
`0021 0
`
`Registration
`
`As attOIneyI's) or age-nits) to represent the undersigned before the United States Patent and'iradernark Ofiice (USPTO) in connection with
`any and ail patent appIIcatEIOIs assignedwaniv to the undersIgned according It: the LJSPTO assignrnent-records or assignments documents
`attached to this formin accordance with 37 CFR 3.73(9).
`
`The address associated with Customer Number:
`
`individual Name
`
`Country
`
`Telephone
`
`.........+.........
`
`Assignee Name and Addressr Cubist Pharmaceuticals LLC
`
`2000 Galloping Hill Road
`Kenilworth, New Jersey 07033
`
`A cepy of this form, together with a statement under 3‘! CFR 3.73m) {Form PTOI’AEAI’QS or equivaient) is required to be
`Filed in each application in which this form is used. The statement under 37 CFR 313(6) may be completed by one of
`The
`ractitieners a
`ointed in this term and must identif
`the a
`iication in which this Power oi Attorne is to be filed
`
`$EGNATURE of Assignee of Renard
`The individual whose signature and litie is supplied iaetow is authorir d to act cm behatf of tt“
`
`signature
`
`/Laura M. Ginkel, Reg. No. 51 ,737/
`
`Tfiiephom 732-594-1932
`
`
`is .equ ‘0‘ to 0
`
`
`(and
`tail
`
`into
`cotlection o. inimmaticr
`ecuir‘ed by
`.
`Ior Ietaih a bene
`by he put) w
`
`
`
`by the USPTC
`plication.
`(-‘0nfide-1..I
`" I :l byas U .S.C. 152.. enmi 37 "FR 1 11 and1.14.
`s coilectioi'
`estimated to take 3 minutes
`
`
`
`
`
`3. the completed applicatidn farm ‘IoIhe USPTO Time wiii vary {IepeIIIdirIg uooII the individua: case. Any
`to corriplete including game
`9, pieoaring and 8'l)m
`
`
`LlilB t0 compIIete this term anti/Gr suggestionIs for reducing th
`comments on the amoLrIt DI time. yau r
`' urclen should hJ6 sent to the Chier"Information Ohicer.
`
`US. Patent and Trademark Office, US. Department 01 Commerce, PO. Box 1450, Aiexandria. VA 2
`.-1450.DO NOT SEND.EES OR COII’lFL ETED
`FCIRMS 'I'ID Tl-iiS ADDRESS. SEND TO: Commissioner for Patents. PD. Box 1450, Aiexandria. VA 22313-1450.
`
`it you need assistance In completing the form, call 130043109: ”SIS and select option 2,
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`Privacy Act Statement
`
`The Privacy Act of WW (PA... Q3~5Y§i requires that you be given certain information in connection with your
`submission of the attached form related to a patent application or patent. Accordingiy, pursuant to the
`requirements of the Act, piease be advised that: (’i) the generai authority for the coilection of this information is 35
`U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principai purpose for which the
`information is used by the 1.1.8. Patent and Trademark Office is to process and/or examine your submission
`reiated to a patent appiication or patent. if you do not furnish the requested infor ration, the US. Patent and
`Trademark Office may not be abie to process and/or examine your submission, which may resuit in termination of
`proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form wiil be subject to the foiiowing routine uses:
`
`The information on this form wili be treated confidentially to the extent ailowed under the Freedom of
`information Act (5 USC. 552) and the Privacy Act (5 U313 552a). Records from this system of records
`may be disciosed to the Department of Justice to determine whether disciosure of these records is
`required by the Freedom of information Act.
`
`A record from this system of records may be disciosed, as a routine use, in the course of presenting
`evidence to a court‘ magistrate, or administrative tribunal. inciuding disclosures to opposing counsei in
`the course of settiement negotiations.
`
`A record in this system of records may be disciosed‘ as a routine use. to a Member of Congress
`submitting a request invoiving an individuai, to whom the record pertains, when the individuai has
`requested assistance from the Member with respect to the subject matter of the record.
`
`A record in this system of records may be disciosed, as a routine use, to a contractor of the Agency
`having need for the information in order to perform a contract. Recipients of information shaii be required
`to comply with the requirements of the Privacy Act of 18.74, as amended, pursuant to 5 USE. 5523(m).
`
`or
`
`A record related to an international Appiication filed under the Patent Cooperation Treaty in this system of
`records may be disclosed) as a routine use, to the internationai Bureau of the Worid inteilectuai Property
`Organization, pursuant to the Patent Cooperation Treaty.
`
`A record in this system of records may be disciosed, as a routine use, to anotherfederai agency for
`purposes of National Security review (35 USC. 181) and for review pursuant to the Atomic Energy Act
`(42 USC. 218(c)}.
`
`A record from this system of records may he disciosed, as a routine use, to the Administrator, General
`Services, or his/her designee. during an inspection of records conducted by GSA as part of that agency’s
`responsibiiity to recommend improvements in records management practices and programs, under
`authority of 44 USS. 29134 and 2966. Such disciosure shali be made in accordance with the GSA
`reguiations governing inspection of records for this purpose, and any other reievant (Le, GSA or
`Commerce) directive. Such disciosure shall not be used to make determinations about individuais.
`
`A record from this system of records maybe disciosed. as a routine use. to the pubiic after either
`pubiication ot the application pursuant to 35 USS. 122(b) or issuance of a patent pursuant to 35 USS.
`151. Further, a record may be disciosed, subject to the iimitations of ’37 CFR 1.14, as a routine use. to the
`pubiic if the record was i'iied in an appiication which became abandoned or in which the proceedings were
`terminated and which application is referenced by either a pubiished appiication. an application open to
`pubiic inspection or an issued patent.
`
`A record from this system of records may be disciosed. as a routine use. to a Federai, State, or local law
`enforcement agency. if the USPTO becomes aware of a violation or potential vioiation oi" law or
`reguiation.
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`MERCK & CO., INC.
`
`CERTIFICATION
`
`I, Katie E. Fedosz, Senior Assistant Secretary of Merck & Co., Inc. (the
`
`“Company”), a corporation duly organized and existing under the laws of the State of
`
`New Jersey, United States of America, do hereby certify that the attached, presently in
`
`full force and effect, is a true and correct copy of General Corporate Resolution #5,
`
`Patent Matters, as amended and readopted the Board of Directors of said Company at
`
`a meeting thereof duly called and held on July 22, 2015, at which a quorum of Directors
`
`was present.
`
`IN WITNESS WHEREOF, I have hereunto subscribed my signature and
`
`affixed the seal of the Company this 22nd day of July, 2015.
`
`Senior Assistant Secretgv:
`
`(SEAL)
`
`United States of America)
`State of New Jersey
`County of Hunterdon
`
`)
`
`) SS
`
`Subscribed and sworn to before me on this 22nd day of July, 2015.
`
`42,291 Wflfi i WW1
`
`Notary Public
`
`SANDRA MARIE MCFADDEN
`NOTARY PUBLIC, STATE OF NEW JERSEY
`MY COMMISSION EXPIRES JANUARY 18, 2020
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`Page 1 of 1
`Amended 7/22/15
`
`General Corporate Resolution #5
`
`PATENT MATTERS
`
`RESOLVED, that any of the following:
`
`Kenneth C. Frazier — Chairman, President and Chief Executive Officer
`Michael J. Holston — Executive Vice President and General Counsel
`William Krovatin — Senior Vice President and Assistant General Counsel
`
`Mark R. Daniel — Associate Vice President and Group Managing Counsel
`Gerard M. Devlin, Jr. — Managing Counsel, IP Litigation
`Catherine D. Fitch — Managing Counsel, Patents
`Laura M. Ginkel — Managing Counsel, Patents
`Sheldon O. Heber * Senior Counsel, Patents
`J.J.L. Mestrom — Managing Counsel, lP Animal Health
`Mary J. Morry — Senior Counsel, IP Litigation
`lmmac Thampoe — Managing Counsel, Biologics
`John C. Todaro — Managing Counsel, Patents
`Anna L. Cocuzzo — Assistant Managing Counsel, Biologics
`Gloria Fuentes —Assistant Managing Counsel, Biologics
`James Horgan — Assistant Managing Counsel, European Patents
`Cynthia A. Francisco — Director, Asset Management
`
`are authorized to execute and to revoke on behalf of Merck & Co., Inc. and its affiliates
`(including subsidiaries) the following documents relating to patent matters:
`
`Powers of attorney as fully in law as may be necessary and proper in connection with
`the acquisition, registration, maintenance and enforcement of patents and applications
`for patents, including powers of attorney relating to the prosecution or defense of patent
`rights before courts of law or other governmental tribunals, agencies or departments;
`affidavits and declarations; and any other documents which are necessary and proper
`for the acquisition, registration, maintenance, litigation and protection of patents.
`
`
`
` Proprietary
`
`AMNEAL EX. 1002
`
`AMNEAL EX. 1002
`
`

`

`PTO/AlA/QB (08-12)
`Approved for use through 01/31/2013. OMB 0651-0031
`US. Patent and Trademark Office:U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of1995. no persons arereqUIred to respond to a collection of information unless it displays a valid OMB control number.
`
`Applicant/Patent Owner